Extendicare (OTCMKTS:EXETF – Get Free Report) is anticipated to post its results after the market closes on Thursday, August 6th. Analysts expect Extendicare to announce earnings of $0.2781 per share and revenue of $399.3230 million for the quarter.
Extendicare Trading Down 3.1%
Shares of EXETF stock opened at $24.52 on Wednesday. Extendicare has a 1 year low of $8.95 and a 1 year high of $28.45. The firm’s 50 day moving average is $25.00 and its 200-day moving average is $21.65.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on EXETF. TD Securities reaffirmed a “buy” rating on shares of Extendicare in a report on Monday, May 11th. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Extendicare in a research report on Monday, May 11th. Five analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy”.
Extendicare Company Profile
Extendicare Inc (OTCMKTS:EXETF) is a Canada-based senior care provider headquartered in Markham, Ontario. The company specializes in the ownership and operation of long-term care homes, retirement residences and home health care services. It is publicly listed on the Toronto Stock Exchange under the symbol EXE and trades in the over-the-counter market as EXETF.
Extendicare’s operations are organized into two primary segments. The Long-Term Care & Retirement Living division operates approximately 120 facilities under the Extendicare and EspritVitalité banners, serving residents in Ontario, Alberta, Saskatchewan and parts of Atlantic Canada.
Featured Stories
- Five stocks we like better than Extendicare
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
